Concepedia

Pan Tong

PT

Statistics

Publications

17

Citations

2.2K

H-Index

14

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Jilin University

The University of Texas Southwestern Medical Center

BioMarin (United States)

Pan Tong is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2013–2024

17

Publications

17

A pan-cancer proteomic perspective on The Cancer Genome Atlas

Rehan Akbani, Patrick Kwok Shing Ng, Henrica M.J. Werner et al. · Nature Communications · 2014 · 636 citations · Full text

, , +14

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Limo Chen, Lixia Diao, Yongbin Yang et al. · Cancer Discovery · 2018 · 471 citations

, , +17

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 227 citations · Full text

, , +17

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart et al. · Cancer Research · 2017 · 195 citations

, , +17

Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers

Monique B. Nilsson, Huiying Sun, Lixia Diao et al. · Science Translational Medicine · 2017 · 153 citations

, , +14

1–5 of 17